Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 346 AL 360

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease

Harris SA, Harris EA.

J Alzheimers Dis. 2015;48(2):319-53. doi: 10.3233/JAD-142853.

Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects

Lewczuk P, Kornhuber J; German Dementia Competence Network; Toledo JB, Trojanowski JQ, Knapik-Czajka M, Peters O, Wiltfang J, Shaw LM; US-ADNI.

J Alzheimers Dis. 2015;48(2):433-41. doi: 10.3233/JAD-150342.

Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis

Liao X, Li G, Wang A, Liu T, Feng S, Guo Z, Tang Q, Jin Y, Xing G, McClure MA, Chen H, He B, Liu H, Mu Q.

J Alzheimers Dis. 2015;48(2):463-72. doi: 10.3233/JAD-150346.

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Kubo M, Kishi T, Matsunaga S, Iwata N.

J Alzheimers Dis. 2015;48(3):667-71. doi: 10.3233/JAD-150393.

Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease

Wang C, Tan L, Wang HF, Yu WJ, Liu Y, Jiang T, Tan MS, Hao XK, Zhang DQ, Yu JT; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(2):491-5. doi: 10.3233/JAD-150110.

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions

Bhat NR.

J Alzheimers Dis. 2015;46(3):581-91. doi: 10.3233/JAD-150098.

Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis

Wang H, Tan L, Wang HF, Liu Y, Yin RH, Wang WY, Chang XL, Jiang T, Yu JT.

J Alzheimers Dis. 2015;46(4):1049-70. doi: 10.3233/JAD-143225.

Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease

Moosavi B, Mousavi B, Macreadie IG.

J Alzheimers Dis. 2015;47(1):9-16. doi: 10.3233/JAD-150173.

The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease

Groblewska M, Muszyński P, Wojtulewska-Supron A, Kulczyńska-Przybik A, Mroczko B.

J Alzheimers Dis. 2015;47(1):17-32. doi: 10.3233/JAD-150060.

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.

J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.

A Novel AβPP M722K Mutation Affects Amyloid-β Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals

Wang Q, Jia J, Qin W, Wu L, Li D, Wang Q, Li H.

J Alzheimers Dis. 2015;47(1):157-65. doi: 10.3233/JAD-143231.

Editorial

Kullmann DM.

Brain. 2015 Oct;138(Pt 10):2801. doi: 10.1093/brain/awv273.

The A-B-C for SORting APP

Coulson EJ, Andersen OM.

J Neurochem. 2015 Oct;135(1):1-3. doi: 10.1111/jnc.13231.

Cerebral perfusional effects of 1-year rivastigmine treatment in Alzheimer disease: a case report

Ettorre E, Bersani FS, Colella F, Servello A, Minichino A, Megna V, Liberatore M, Biondi M, Marigliano V.

Riv Psichiatr. 2015 Jul-Aug;50(4):188-91. doi: 10.1708/2002.21650.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias